In our September issue:
FEATURED
The Changing Site Landscape
Cindy H. Dubin
The rising complexity in clinical trial research is adding further challenge to investigative sites already dealing with things like varied performance, increasing staff workloads, limited access to data analytics, and difficulty finding patients. This article explores how sites are redefining their business models to be more flexible, collaborative, and customized.
Expert Panel Tackles Data Sharing
Jason Methia
Industry executives from across academia, sites, CROs, and sponsors converge to discuss the current hurdles in information exchange in clinical trials—and the steps, technologies, and mindset necessary to strengthen data sharing among study partners.
Trial Reform in Action
Sony Salzman
The U.S. Department of Veterans Affairs (VA) has a long history of pioneering clinical research, but in recent decades, its efforts have been inwardly focused, with little collaboration with the private sector, resulting in slow study start-ups. That may be changing, however, as the VA implements its multi-year initiative to bolster clinical research.
Executive Profile: Championing Trial Diversity
Christen Harm
Applied Clinical Trials speaks with Charlotte Jones-Burton, Bristol-Myers Squibb's cardiovascular development team lead, who shares insights on the importance of diversifying clinical trials to help deliver improved patient outcomes.
|
NEWS
Eye on Patient Advocacy: Fourth column in series presents a case study on retention strategies for keeping trial participants engaged.
Washington Report: Jill Wechsler on the cautious climate for implementing risk-based oversight of clinical trials, despite urging from regulators.
EU Report: Peter O'Donnell looks at the seemingly endless debate around sponsor influence on European drug evaluators.
Q&A: CEO of informatics and e-learning company discusses the impact of healthcare technology on site-readiness practices.
|
CLINICAL TRIAL INSIGHTS
Benchmarking Rare Disease R&D
Ken Getz
Tufts CSDD compiles useful benchmarks on rare disease drug development performance and economics, as interest from sponsors and CROs in this data to guide portfolio and R&D project planning and optimization has grown.
|
CLOSING THOUGHT
New Tech: Putting Sites First
KK Rumrill
More work needs to be done to help sites become less wary of new technology. There are several steps organizations can take to implement a site-first approach that ensures their tools aren't missing the mark.
|
|
|
If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lhenderson@mmhgroup.com
Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.
Click here to contact the Applied Clinical Trials sales team. |
